STAT Plus: Lawmakers urge federal watchdog to probe government’s role in discovering remdesivir
Amid concerns over access to medicines that were hatched with U.S. taxpayer funds, Democratic lawmakers…
Category: Pharma
STAT Plus: Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain
Hello, everyone, and how are you today? We are doing reasonably well, given the circumstances….
Pfizer and BioNTech pick Covid-19 vaccine and begin pivotal study
Pfizer and BioNTech are starting a large study of a vaccine candidate for Covid-19 aimed…
STAT Plus: New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug
A New York State panel has recommended that officials seek a supplemental Medicaid rebate for…
STAT Plus: Generic group fails again to block California law that bans pay-to-delay deals
A federal appeals court denied a bid by a pharmaceutical industry trade group to block…
STAT Plus: Pharmalittle: Moderna gets $472 million as late-stage Covid-19 vaccine trial begins; EU turns away from WHO vaccine effort
Good morning, everyone, and nice to see you again. We have returned, so to speak,…
STAT Plus: Pharmalittle: Moderna loses a key patent decision; China says its Covid-19 vaccine will be ready this year
Good morning and happy Friday. Elizabeth Cooney here, thinking of the vacationing Ed Silverman’s weekly…
STAT Plus: ‘Inactive’ drug ingredients are not always inactive, study finds
What’s in that pill you just swallowed? The label on the bottle lists the drug’s…
STAT Plus: Pharmalittle: NIH launching ‘flurry’ of Covid-19 treatment trials; Pfizer-BioNTech deal sets ceiling for vaccine price
Good morning. Elizabeth Cooney here, filling in for Ed Silverman until he returns from vacation…
STAT Plus: Pharmalittle: U.S. to pay $1.95b for Pfizer-BioNTech Covid-19 vaccine; who decides who gets the first doses?
Good morning. Elizabeth Cooney here, channeling the vacationing Ed Silverman’s Wednesday wisdom: We’ve made it…
STAT Plus: Pharmalittle: Covid-19 vaccines may need two doses; lawmakers grilling pharma execs own their stocks
Good morning. Elizabeth Cooney here again, subbing for the vacationing Ed Silverman as the week…
STAT Plus: Pharmalittle: U.K. inks coronavirus vaccine deal; Synairgen says its drug lowers Covid-19 risk
Good morning. Elizabeth Cooney here in Boston, sitting in for Ed Silverman, who’s on holiday…
STAT Plus: Pharmalittle: Hydroxychloroquine fails once more; Russian hackers target coronavirus vaccine data
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT Plus: Operation Warp Speed doesn’t have the transparency it needs
So much for transparency. In what can only be called a disappointing decision, the Trump…
STAT Plus: Novartis to provide drugs for Covid-19 patients at no cost, but fails to disclose pricing
As companies face pressure to ensure access to medicines during the pandemic, Novartis (NVS) plans…
STAT Plus: Pharmalittle: Warp Speed chief can avoid ethics disclosures; China OKs a BioNTech Covid-19 vaccine trial
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: Moderna vaccine is a ‘good beginning’; hospitals stock up on drugs for Covid-19
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT Plus: AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
The pricey Imbruvica cancer treatment that became available seven years ago could have its monopoly…
STAT Plus: Drug maker offers to slash prices on cancer medicines to end European price gouging probe
In response to a probe into alleged price gouging, Aspen Pharma has agreed to slash…
STAT Plus: Sun Pharma employee says she was fired for complaining that samples were improperly shipped
A former Sun Pharmaceutical sales rep filed a lawsuit arguing she was fired from her…
STAT Plus: Ohio sues Express Scripts for ‘egregiously’ overcharging for medicines
The Ohio Attorney General has filed a lawsuit alleging Express Scripts overcharged a state pension…
.jpg)
STAT Plus: Pharmalittle: Pharma ramps up clinical trials after Covid-19 delays; skepticism high over vaccine profits and global distribution
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT Plus: Sanofi and MD Anderson team up to accelerate cancer drug testing
In another sign of its renewed emphasis on cancer, Sanofi (SNY) said Tuesday it will…
STAT Plus: European Parliament backs WHO effort to create a Covid-19 technology access pool
In an overwhelming vote, the European Parliament late last week voted to support a World…
.jpg)
STAT Plus: Pharma trade group scolds Gilead again for misleading information about a rival HIV drug
For the second time in less than two years, Gilead Sciences (GILD) has been reprimanded…
STAT Plus: Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: How can cancer drug prices better match their benefits? Germany offers a cost-saving model
A new study finds that after Germany revamped its approach to purchasing medicines a decade…
STAT Plus: Pharmalittle: BioNTech expects to seek approval for vaccine by year-end; why the FDA chose a 50% threshold for Covid-19 vaccines
And so, another working week will soon draw to a close. Not a moment too…
Despite the pandemic, prices for many drugs keep rising
Despite the economic hardships the Covid-19 pandemic has created for many Americans, drug makers raised…
STAT Plus: Two dozen big drug makers launch a $1 billion fund to develop new antibiotics
In response to heightened concerns over antibiotic resistance, two dozen of the world’s largest pharmaceutical…
STAT Plus: Pharmalittle: Gilead to boost remdesivir supplies in Europe; drug makers announcing $1 billion antibiotic innovation fund
Good morning, everyone, and welcome to another busy day. You made it this far this…
The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says
Earlier this week, a Canadian company called Medicago struck two deals to supply its plant-based…
STAT Plus: Pharmalittle: Will a coronavirus vaccine be budget-breaking? Europe has deals with Merck and Roche for Covid-19 drugs
Rise and shine, another busy day is on the way. We can tell because the…
STAT Plus: Did a pharma trade group try to sabotage a Dutch government report on compulsory licensing?
A Dutch government commission on compulsory licensing was nearly sabotaged last month after one of…
STAT+ Conversations: A conversation with Eli Lilly
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET. …
STAT Plus: Pharmalittle: U.S. scientists and Moderna squabble over Covid-19 vaccine; BARDA doles out big coronavirus contract
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: Lobbyists tied to President Trump represent more than a dozen companies working on Covid-19
More than a dozen companies developing Covid-19 vaccines, therapies or diagnostics — including several of…
STAT Plus: Johnson & Johnson lowers the price of its TB drug in many poor countries, but is it enough?
After protracted criticism over its pricing for a game-changing tuberculosis medicine, Johnson & Johnson (JNJ)…
STAT Plus: Pharmalittle: Covid-19 trials are marked by disorganization; FDA approves a new type of HIV treatment
Good morning, everyone, and welcome to another working week. We hope the weekend respite, which…
STAT Plus: Alexion to pay $21 million for failing to record bribes paid to doctors in other countries
Alexion Pharmaceuticals (ALXN) agreed to pay more than $21 million for maintaining a false set…
STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
And so, another working week will soon come to an end. Not a moment too…
STAT Plus: Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors
After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle…
STAT Plus: Africa Union urges member countries to remove intellectual property barriers to Covid-19 vaccines
Amid growing concern over access to Covid-19 medical products, the organization that represents dozens of…
STAT Plus: Pharmalittle: FDA sets Covid-19 vaccine guidance; White House grabs much of the remdesivir supply
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
Some U.S. government contracts for Covid-19 research could skirt affordable pricing laws
A new report finds that the U.S. government awarded several drug makers contracts for coronavirus research using…
STAT Plus: Indivior CEO pleads guilty in connection with a scheme to promote Suboxone
The chief executive of Indivior pleaded guilty to misbranding Suboxone Film, a medicine used to…
STAT Plus: Canadian court upholds most of a controversial new rule for controlling excessive drug prices
In a setback to the pharmaceutical industry, a federal court judge in Canada has dismissed…
STAT Plus: After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
U.K. officials and Vertex Pharmaceuticals (VRTX) have finally put to rest a years-long battle over…
STAT+ Conversations: The state of the pharmaceutical industry, featuring Pharmalot’s Ed Silverman
Editor’s note: A livestream of this conversation will be embedded below at 1 p.m. ET. …
Inovio claims positive results on Covid-19 vaccine but critical data are missing
Inovio Pharmaceuticals on Tuesday said that its investigational Covid-19 vaccine had “positive” results in a…